An unanswerable question? Adjuvant and neoadjuvant treatment of breast cancer
Niraparib as maintenance for platinum-sensitive ovarian cancer - results from ENGOT-OV16/NOVA trial
Phase 1b trial of CRS-207 with chemotherapy for malignant pleural mesothelioma
PARP inhibitors: game-changers for ovarian cancer patients?
Mansoor Raza Mirza
Update on Study 19 trial of olaparib in serous ovarian cancer